Los Angeles Capital Management
SYNH

Los Angeles Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Los Angeles Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-42,171
Closed -$2.21M – 1412
2017
Q3 		$2.21M Buy
+42,171
New +$2.35M 0.01% 595

Other funds holding SYNH

THLTP
Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return
AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Los Angeles Capital Management's SYNH Position: Q4 2017 in Review

Los Angeles Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2017, closing a stake of 42,171 shares — an estimated $2.21M sold.

Los Angeles Capital Management first reported a position in SYNH in Q3 2017 and held it in 1 quarter. The position peaked at $2.21M in Q3 2017. 194 funds tracked by Wall St. Rank hold SYNH as of Q4 2017.

  • Los Angeles Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2017 after selling out during the quarter.
  • Los Angeles Capital Management sold 42,171 Syneos Health, Inc. Class A Common Stock shares in Q4 2017, an estimated $2.21M.
  • Los Angeles Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2017 and held it in 1 quarter.
  • Los Angeles Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $2.21M in Q3 2017.
  • 194 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2017.

Based on Los Angeles Capital Management's 13F filing for Q4 2017, filed 5 Feb 2018.